Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overlap of International League of Associations for Rheumatology and Preliminary Pediatric Rheumatology International Trials Organization Classification Criteria for Nonsystemic Juvenile Idiopathic Arthritis in an Established UK Multicentre Inception Cohort.
Shoop-Worrall SJW, Macintyre VG, Ciurtin C, Cleary G, McErlane F, Wedderburn LR; Childhood Arthritis Prospective Study (CAPS) Principal Investigators; Hyrich KL. Shoop-Worrall SJW, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2024 Jun;76(6):831-840. doi: 10.1002/acr.25296. Epub 2024 Mar 15. Arthritis Care Res (Hoboken). 2024. PMID: 38212149
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study.
Hyrich KL, Lal SD, Foster HE, Thornton J, Adib N, Baildam E, Gardner-Medwin J, Wedderburn LR, Chieng A, Davidson J, Thomson W. Hyrich KL, et al. Rheumatology (Oxford). 2010 Jan;49(1):116-22. doi: 10.1093/rheumatology/kep352. Epub 2009 Nov 19. Rheumatology (Oxford). 2010. PMID: 19926670 Free PMC article.
Association of the CCR5 gene with juvenile idiopathic arthritis.
Hinks A, Martin P, Flynn E, Eyre S, Packham J; Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR Study Group; Barton A, Worthington J, Thomson W. Hinks A, et al. Genes Immun. 2010 Oct;11(7):584-9. doi: 10.1038/gene.2010.25. Epub 2010 May 13. Genes Immun. 2010. PMID: 20463745 Free PMC article.
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP; British Society For Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2010 Jun;62(6):755-63. doi: 10.1002/acr.20129. Arthritis Care Res (Hoboken). 2010. PMID: 20535785 Free PMC article.
Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
Southwood TR, Foster HE, Davidson JE, Hyrich KL, Cotter CB, Wedderburn LR, Hull RG, Venning HE, Rahman JK, Cummins CL; British Society for Adolescent and Paediatric Rheumatology Biologics and New Drugs Register. Southwood TR, et al. Among authors: hyrich kl. Rheumatology (Oxford). 2011 Jan;50(1):189-95. doi: 10.1093/rheumatology/keq308. Epub 2010 Nov 3. Rheumatology (Oxford). 2011. PMID: 21047801
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
Soliman MM, Hyrich KL, Lunt M, Watson KD, Symmons DP, Ashcroft DM; British Society for Rheumatology Biologics Register. Soliman MM, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2012 Aug;64(8):1108-15. doi: 10.1002/acr.21663. Arthritis Care Res (Hoboken). 2012. PMID: 22422731 Free PMC article.
270 results